Acidic pHe regulates cytoskeletal dynamics through conformational integrin β1 activation and promotes membrane protrusion

An acidic extracellular pH (pHe) in the tumor microenvironment has been suggested to facilitate tumor growth and metastasis. However, the molecular mechanisms by which tumor cells sense acidic signal to induce a transition to an aggressive phenotype remain elusive. Here, we showed that an acidic pHe (pH?6.5) stimulation resulted in protrusion and epithelial-mesenchymal transition (EMT) of cancer cells, which promoted migration and matrix degeneration. Using computational molecular dynamics simulations, we reported acidic pHe-induced opening of the Integrin dimers (α5β1) headpiece which indicated the activation of integrin. Moreover, acidic pHe promoted maturation of focal adhesions, temporal activation of Rho GTPases and microfilament reorganization through integrin β1-activated FAK signaling. Furthermore, mechanical balance of cytoskeleton (actin, tubulin and vimentin) contributed to acidic pHe-triggered protrusion and morphology change. Taken together, these findings revealed that integrin β1 could be a novel pH-regulated sensitive molecule which confers protrusion and malignant phenotype of cancer cells.     

The acid-base transport proteins NHE1 and NBCn1 regulate cell cycle progression in human breast cancer cells

Precise acid-base homeostasis is essential for maintaining normal cell proliferation and growth. Conversely, dysregulated acid-base homeostasis, with increased acid extrusion and marked extracellular acidification, is an enabling feature of solid tumors, yet the mechanisms through which intra- and extracellular pH (pH_i, pH_e) impact proliferation and growth are incompletely understood. The aim of this study was to determine the impact of pH, and specifically of the Na⁺/H⁺ exchanger NHE1 and Na⁺, HCO₃^? transporter NBCn1, on cell cycle progression and its regulators in human breast cancer cells. Reduction of pH_e to 6.5, a common condition in tumors, significantly delayed cell cycle progression in MCF-7 human breast cancer cells. The NHE1 protein level peaked in S phase and that of NBCn1 in G2/M. Steady state pH_i changed through the cell cycle, from 7.1 in early S phase to 6.8 in G2, recovering again in M phase. This pattern, as well as net acid extrusion capacity, was dependent on NHE1 and NBCn1. Accordingly, knockdown of either NHE1 or NBCn1 reduced proliferation, prolonged cell cycle progression in a manner involving S phase prolongation and delayed G2/M transition, and altered the expression pattern and phosphorylation of cell cycle regulatory proteins. Our work demonstrates, for the first time, that both NHE1 and NBCn1 regulate cell cycle progression in breast cancer cells, and we propose that this involves cell cycle phase-specific pH_i regulation by the two transporters.     

Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers

Magnetic targeted drug delivery (MTD), using magnetic gold nanoparticles (Fe₃O₄@Au NPs) conjugated with an anti-cancer drug is a promise modality for cancer treatment. In this study, Fe₃O₄@Au NPs were prepared and functionalized with thiol-terminated polyethylene glycol (PEG), then loaded with anti-cancer drug doxorubicin (DOX). The physical properties of the prepared NPs were characterized using different techniques. Transmission electron microscopy (TEM) revealed the mono dispersed nature of Fe₃O₄@Au NPs with an average size of 20 nm which was confirmed using Dynamic light scattering (DLS) measurements. Zeta potential measurements along with UV–VIS spectroscopy demonstrated surface DOX loading on Fe₃O₄@Au NPs. Energy Dispersive X-ray Spectroscopy (EDX) assured the existence of both iron and gold elements in the prepared NPs. The paramagnetic properties of the prepared NPs were assessed by vibrating sample magnetometer (VSM). The maximum DOX-loading capacity was 100 μg DOX/mg of Fe₃O₄@Au NPs. It was found that DOX released more readily at acidic pH. In vitro studies on MCF-7 cell line elucidated that DOX loaded Fe₃O₄@Au NPs (Fe₃O₄@Au-PEG-DOX) have more potent therapeutic effect than free DOX. Knowledge gained in this study may open the door to pursue Fe₃O₄@Au NPs as a viable nanocarriers for different molecules delivery in many diagnostic and therapeutic applications.     

Fabrication and Intracellular Delivery of Doxorubicin/Carbonate Apatite Nanocomposites: Effect on Growth Retardation of Established Colon Tumor

In continuing search for effective treatments of cancer, the emerging model aims at efficient intracellular delivery of therapeutics into tumor cells in order to increase the drug concentration. However, the implementation of this strategy suffers from inefficient cellular uptake and drug resistance. Therefore, pH-sensitive nanosystems have recently been developed to target slightly acidic extracellular pH environment of solid tumors. The pH targeting approach is regarded as a more general strategy than conventional specific tumor cell surface targeting approaches, because the acidic tumor microclimate is most common in solid tumors. When nanosystems are combined with triggered release mechanisms in endosomal or lysosomal acidic pH along with endosomolytic capability, the nanocarriers demonstrated to overcome multidrug resistance of various tumors. Here, novel pH sensitive carbonate apatite has been fabricated to efficiently deliver anticancer drug Doxorubicin (DOX) to cancer cells, by virtue of its pH sensitivity being quite unstable under an acidic condition in endosomes and the desirable size of the resulting apatite-DOX for efficient cellular uptake as revealed by scanning electron microscopy. Florescence microscopy and flow cytometry analyses demonstrated significant uptake of drug (92%) when complexed with apatite nanoparticles. In vitro chemosensitivity assay revealed that apatite-DOX nanoparticles executed high cytotoxicity in several human cancer cell lines compared to free drugs and consequently apatite-DOX-facilitated enhanced tumor inhibitory effect was observed in colorectal tumor model within BALB/cA nude mice, thereby shedding light on their potential applications in cancer therapy.     

In Vivo Microdialysis of 2-Deoxyglucose 6-Phosphate into Brain

Abstract : A unique method for simultaneously measuring interstitial (pH_e) as well as intracellular (pH_i) pH in the brains of lightly anesthetized rats is described. A 4-mm microdialysis probe was inserted acutely into the right frontal lobe in the center of the area sampled by a surface coil tuned for the collection of ³¹P-NMR spectra. 2-Deoxyglucose 6-phosphate (2-DG-6-P) was microdialyzed into the rat until a single NMR peak was detected in the phosphomonoester region of the ³¹P spectrum. pH_e and pH_i values were calculated from the chemical shift of 2-DG-6-P and inorganic phosphate, respectively, relative to the phosphocreatine peak. The average in vivo pH_e was 7.24 ± 0.01, whereas the average pH_i was 7.05 ± 0.01 (n = 7). The average pH_e value and the average CSF bicarbonate value (23.5 ± 0.1 mEq/L) were used to calculate an interstitial Pco₂ of 55 mm Hg. Rats were then subjected to a 15-min period of either hypercapnia, by addition of CO₂ (2.5, 5, or 10%) to the ventilator gases, or hypocapnia (Pco₂ < 30 mm Hg), by increasing the ventilation rate and volume. pH_e responded inversely to arterial Pco₂ and was well described (r² = 0.91) by the Henderson-Hassel-balch equation, assuming a pK_a for the bicarbonate buffer system of 6.1 and a solubility coefficient for CO₂ of 0.031. This confirms the view that the bicarbonate buffer system is dominant in the interstitial space. pH_i responded inversely and linearly to arterial Pco₂. The intracellular effect was muted as compared with pH_e (slope = -0.0025, r² = 0.60). pH_e and pH_i values were also monitored during the first 12 min of ischemia produced by cardiac arrest. pH_e decreases more rapidly than pH_i during the first 5 min of ischemia. After 12 min of ischemia, pH_e and pH_i values were not significantly different (6.44 ± 0.02 and 6.44 ± 0.03, respectively). The limitations, advantages, and future uses of the combined microdialysis/³¹P-NMR method for measurement of pH_e and pH_i are discussed.     

Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers

Rapid growth in nanotechnology toward the development of nanomedicine agents holds massive promise to improve therapeutic approaches against cancer. Nanomedicine products represent an opportunity to achieve sophisticated targeting strategies and multifunctionality. Nowadays, nanoparticles (NPs) have multiple applications in different branches of science. In recent years, NPs have repetitively been reported to play a significant role in modern medicine. They have been analyzed for different clinical applications, such as drug carriers, gene delivery to tumors, and contrast agents in imaging. A wide range of nanomaterials based on organic, inorganic, lipid, or glycan compounds, as well as on synthetic polymers has been utilized for the development and improvement of new cancer therapeutics. In this study, we discuss the role of NPs in treating cancer among different drug delivery methods for cancer therapy.     

Tumor-targeted pH-low insertion peptide delivery of theranostic gadolinium nanoparticles for image-guided nanoparticle-enhanced radiation therapy

Tumor targeting studies using metallic nanoparticles (NPs) have shown that the enhanced permeability and retention effect may not be sufficient to deliver the amount of intratumoral and intracellular NPs needed for effective in vivo radiosensitization. This work describes a pH-Low Insertion Peptide (pHLIP) targeted theranostic agent to enable image-guided NP-enhanced radiotherapy using a clinically feasible amount of injected NPs. Conventional gadolinium (Gd) NPs were conjugated to pHLIPs and evaluated in vitro for radiosensitivity and in vivo for mouse MRI. Cultured A549 human lung cancer cells were incubated with 0.5 mM of pHLIP-GdNP or conventional GdNP. Mass spectrometry showed 78-fold more cellular Gd uptake with pHLIP-GdNPs, and clonogenic survival assays showed 44% more enhanced radiosensitivity by 5 Gy irradiation with pHLIP-GdNPs at pH 6.2. In contrast to conventional GdNPs, MR imaging of tumor-bearing mice showed pHLIP-GdNPs had a long retention time in the tumor (>9 h), suitable for radiotherapy, and penetrated into the poorly-vascularized tumor core. The Gd-enhanced tumor corresponded with low-pH areas also independently measured by an in vivo molecular MRI technique. pHLIPs actively target cell surface acidity from tumor cell metabolism and deliver GdNPs into cells in solid tumors. Intracellular delivery enhances the effect of short-range radiosensitizing photoelectrons and Auger electrons. Because acidity is a general hallmark of tumor cells, the delivery is more general than antibody targeting. Imaging the in vivo NP biodistribution and more acidic (often more aggressive) tumors has the potential for quantitative radiotherapy treatment planning and pre-selecting patients who will likely benefit more from NP radiation enhancement.     

Development of a Novel DNA Aptamer Ligand Targeting to Primary Cultured Tumor Endothelial Cells by a Cell-Based SELEX Method

The present study used a spontaneous cell-based SELEX method (Systemic Evolution of Ligands by EXponential Enrichment) to produce DNA aptamers that specifically bind to cell surface proteins or biomarkers produced by primary cultured mouse tumor endothelial cells (mTECs). In solid tumors, new blood vessels are formed through an angiogenesis process, and this plays a critical role in cancer development as well as metastasis. To combat angiogenesis, an appropriate diagnosis and a molecular-level understanding of the different cancer types are now a high priority. The novel DNA aptamer AraHH001, developed in this study, binds specifically to mTECs with high affinity in the nano-molar range, but does not bind to normal skin endothelial cells (skin-ECs). The selected DNA aptamer was also found to bind to cultured human tumor endothelial cells (hTECs), isolated from a clinical patient with a renal carcinoma. The aptamer AraHH001 showed significant anti-angiogenesis activity by inhibiting tube formation by mTECs on matrigel. Interestingly, a confocal laser scanning microscopy examination of in vitro cellular uptake revealed that AraHH001 was assimilated by mTECs, and became co-localized in acidic compartments, as detected by labeling with Lysotracker Red. Therefore, the development of a specific DNA aptamer that binds to mTECs, as reported here for the first time, holds great promise not only as a therapeutic aptamer but also as a targeted molecular probe that appears to play a major role in angiogenesis, and for the development of a targeted new drug delivery system.     

The Role of Carbonic Anhydrase 9 in Regulating Extracellular and Intracellular pH in Three-dimensional Tumor Cell Growths

We have studied the role of carbonic anhydrase 9 (CA9), a cancer-associated extracellular isoform of the enzyme carbonic anhydrase in multicellular spheroid growths (radius of ∼300 μm) of human colon carcinoma HCT116 cells. Spheroids were transfected with CA9 (or empty vector) and imaged confocally (using fluorescent dyes) for both intracellular pH (pH_i) and pH in the restricted extracellular spaces (pH_e). With no CA9 expression, spheroids developed very low pH_i (∼6.3) and reduced pH_e (∼6.9) at their core, associated with a diminishing gradient of acidity extending out to the periphery. With CA9 expression, core intracellular acidity was less prominent (pH_i = ∼6.6), whereas extracellular acidity was enhanced (pH_e = ∼6.6), so that radial pH_i gradients were smaller and radial pH_e gradients were larger. These effects were reversed by eliminating CA9 activity with membrane-impermeant CA inhibitors. The observation that CA9 activity reversibly reduces pH_e indicates the enzyme is facilitating CO₂ excretion from cells (by converting vented CO₂ to extracellular H⁺), rather than facilitating membrane H⁺ transport (such as H⁺ associated with metabolically generated lactic acid). This latter process requires titration of exported H⁺ ions with extracellular HCO₃⁻, which would reduce rather than increase extracellular acidity. In a multicellular structure, the net effect of CA9 on pH_e will depend on the cellular CO₂/lactic acid emission ratio (set by local oxygenation and membrane HCO₃⁻ uptake). Our results suggest that CO₂-producing tumors may express CA9 to facilitate CO₂ excretion, thus raising pH_i and reducing pH_e, which promotes tumor proliferation and survival. The results suggest a possible basis for attenuating tumor development through inhibiting CA9 activity.The carbonic anhydrases (CAs)³ are a family of enzymes that reversibly catalyze CO₂ hydration to H⁺ and HCO₃⁻ (1, 2). Recent studies have identified several CA isoforms, such as CA4, CA9, CA12, and CA14, with extracellular-facing catalytic sites (2). Many cells express extracellular CA (CA_e) isoforms, but their physiological role remains unclear. In particular, the strong link between cancer and CA9 expression (1–5) has provoked great interest in the role of CA_e in tumor biology.Based on their topology, CA_e isoforms are likely to regulate the concentration of extracellular H⁺, CO₂, and HCO₃⁻. Cell metabolism drives transmembrane fluxes of H⁺ ions, CO₂ and HCO₃⁻, and can provide substrate for the CA_e-assisted reaction. For example, CO₂ is released from aerobically respiring cells. By consuming or producing H⁺ ions, the CA_e-catalyzed reaction will affect extracellular pH (pH_e). Many membrane proteins are modulated by pH_e (6–8). Some of these are acid/base transporters that regulate intracellular pH (pH_i) (9). Such modulation allows pH_e to cross-talk with pH_i (10, 11), thus helping to shape the plethora of effects that pH_i has on cellular physiology (3, 9, 12, 13). Extracellular pH can also affect tissue structure through the release or modulation of proteolytic enzymes that act on the extracellular matrix (14, 15). In addition, the pH_e-pH_i difference is important in determining the distribution of membrane-permeant weak acids/bases, which include many drugs used clinically (e.g. doxorubicin).A complete understanding of pH regulation at tissue level requires characterization of events occurring within cells, at their surface membrane, and in the surrounding extracellular space. To date, many pH studies have treated the extracellular space as an infinite, well-stirred, and equilibrated compartment of constant pH. This condition is compatible with experimentally superfused, isolated cells, but it may not apply to all cells in situ. Blood plasma is a major component of extracellular fluid. In health, plasma pH is regulated to ∼7.4 by the lungs and kidneys, acting in concert to remove excess acid/base that has been added to blood from dietary or cellular sources. Tissue fluid occupies the gap between plasma and cells (with the exception of blood-borne cells). Under conditions of ideal diffusive coupling between cells and capillaries, pH_e in tissue fluid would be held close to plasma pH. However, pH_e close to the cell surface can diverge from 7.4, particularly when the cell-capillary distance is increased (e.g. as a result of poor blood perfusion), when the excreted acid/base load is elevated, or when the local buffering capacity is compromised.Regulation of pH_e is particularly important in tumors because these are characterized by a high metabolic rate (16, 17) and abnormal blood perfusion (18, 19). Studies have shown that tumors develop low pH_e (∼6.9) in response to the mismatch between metabolic demand and the capacity to remove metabolic waste products (14, 18, 20). Tumors can survive in considerably more acidic interstitium than their non-neoplastic counterparts, partly because of their ability to maintain a favorably alkaline pH_i for growth and development (21). It has been argued that tumors can survive selectively by maintaining a level of pH_e that is lethal to normal cells but not sufficiently acidic to kill the tumor itself (2, 14, 22).A major fraction of cell-derived acid is excreted in the form of CO₂, generated directly from the Krebs cycle or from titration of intracellular H⁺ with HCO₃⁻. To maintain a steep outward gradient for CO₂ excretion, extracellular CO₂ must not accumulate. This can be achieved by venting CO₂ to the nearest capillary or by reacting CO₂ locally to produce H⁺ and HCO₃⁻. The balance between these two fluxes is set by the diffusion distance and CO₂ hydration kinetics, respectively. Diffusion is anecdotally considered to be fast. However, over long distances, CO₂ diffusion may be slower than its local reactive flux. Assuming a CO₂ diffusion coefficient, D_CO2, of 2500 μm²/s and a spontaneous CO₂ hydration rate, k_f, of 0.14 s⁻¹ (23), local CO₂ consumption by reaction will be faster than CO₂ diffusion over distances >190 μm (√(2 × D_CO2/k_f)). The reactive flux can be augmented enzymatically by CA_e, to increase further the importance of reactive versus diffusive consumption of CO₂. If, for instance, hydration is catalyzed 10-fold, reactive CO₂ removal would exceed diffusive CO₂ removal over distances of >60 μm.The remainder of transmembrane acid efflux takes the form of lactic acid, generated from anaerobic respiration or aerobic glycolysis (Warburg effect) (16). Lactic acid efflux can be accelerated if its extracellular concentration is kept low by diffusive dissipation or by CA_e-catalyzed extracellular titration of H⁺ with HCO₃⁻. It is important to note that CA_e-catalyzed hydration of extracellular CO₂ will reduce pH_e, whereas titration of extracellular lactic acid by HCO₃⁻ (to form CO₂, a weaker acid) will raise pH_e. Therefore, the capacity of CA_e to regulate pH_e will depend on the chemistry of the excreted acid. In most healthy tissues at rest, the majority of cellular acid is emitted as CO₂. Recent work on tumors also suggests a dominance of CO₂ over lactic acid (22, 24).The role for CA_e in facilitating CO₂ removal has been demonstrated for CA4 in skeletal muscle (25) and proposed for CA9 in tumors (2, 26). Furthermore, CA9 expression is strongly up-regulated in hypoxia (5), providing a mechanism by which CA9 levels are linked to diffusion distance. A consequence of facilitated CO₂ removal is the attainment of a more uniformly alkaline pH_i across the tissue. We demonstrated this recently in three-dimensional in vitro tissue models imaged for pH_i (23). One prediction from that study is that CA9, although reducing pH_i nonuniformity, will give rise to local extracellular acidity, particularly at the core of multicellular growths.If pH_e is indeed acidified by CA9, the enzyme expression may be doubly beneficial for CO₂-excreting tumors: it will help to attain (i) a favorable alkaline pH_i for growth and (ii) an acidic pH_e to facilitate invasiveness. Clinically, CA9 may serve as a target for drugs. In the present work, we image pH_e using a novel, membrane-impermeant fluorescent pH dye in multicellular spheroid growths (∼35,000 cells) derived from the colon carcinoma cell line HCT116. We demonstrate a key role for CA9 in regulating both pH_i and pH_e. Furthermore, we show that, even in the hypoxic core of spheroids, the principal substrate for CA9 is cell-excreted CO₂ and that the precise effect of CA9 on pH_e depends on the relative efflux from cells of lactic acid versus CO₂.     

Cellular Uptake and Antitumor Activity of DOX-hyd-PEG-FA Nanoparticles

A PEG-based, folate mediated, active tumor targeting drug delivery system using DOX-hyd-PEG-FA nanoparticles (NPs) were prepared. DOX-hyd-PEG-FA NPs showed a significantly faster DOX release in pH 5.0 medium than in pH 7.4 medium. Compared with DOX-hyd-PEG NPs, DOX-hyd-PEG-FA NPs increased the intracellular accumulation of DOX and showed a DOX translocation from lysosomes to nucleus. The cytotoxicity of DOX-hyd-PEG-FA NPs on KB cells was much higher than that of free DOX, DOX-ami-PEG-FA NPs and DOX-hyd-PEG NPs. The cytotoxicity of DOX-hyd-PEG-FA NPs on KB cells was attenuated in the presence of exogenous folic acid. The IC₅₀ of DOX-hyd-PEG-FA NPs and DOX-hyd-PEG NPs on A549 cells showed no significant difference. After DOX-hyd-PEG-FA NPs were intravenously administered, the amount of DOX distributed in tumor tissue was significantly increased, while the amount of DOX distributed in heart was greatly decreased as compared with free DOX. Compared with free DOX, NPs yielded improved survival rate, prolonged life span, delayed tumor growth and reduced the cardiotoxicity in tumor bearing mice model. These results indicated that the acid sensitivity, passive and active tumor targeting abilities were likely to act synergistically to enhance the drug delivery efficiency of DOX-hyd-PEG-FA NPs. Therefore, DOX-hyd-PEG-FA NPs are a promising drug delivery system for targeted cancer therapy.     

Growth inhibition of hybridoma cells by ammonium ion: correlation with effects on intracellular pH

The effect of NH₄Cl addition on intracellular pH (pH _i ) was determined by flow cytometric measurements of the fluorescence of a pH-sensitive dye. The effects of NH₄Cl on growth were determined for batch growth of cells in flasks in an incubator. The addition of NH₄Cl caused a cytoplasmic acidification. A new lower steady-state value of pH _i was attained within 20–40 min of NH₄Cl addition. A correlation was found between the effects of NH₄Cl on growth and on pH _i : whereas 3 mM NH₄Cl had little effect on growth and on pH _i , 10 mM NH₄Cl caused a substantial growth inhibition and a pH _i decrease of 0.2–0.3 units. The effects of NH₄Cl on growth and on pH _i were found to be independent of the external pH value (pH _e over the range 6.8 to 7.6, except that 10 mM NH₄Cl was more toxic at pH _e 7.6. The addition of NH₄Cl caused an increase in the average cell volume at pH _e 7.6, but had no effect on the average cell volume at pH _e 's 6.8 and 7.2. For comparison, the effects of pH _e alone on growth and on pH _i were determined. There was little difference in cell growth at pH _e 's 6.8, 7.2 and 7.6. At pH _e 6.6, there was a substantial growth inhibition. Some measurements of the effects of pH _e on pH _i were made, although the steady-state value of pH _i as a function of pH _e was not determined due to limitations in the pH _i -measuring technique. These measurements showed that pH _i remained constant from pH _e 7.6 to 6.8, but fell by 0.2 units at pH _e 6.6, in agreement with the growth results.     

Alginic Acid-Coated Chitosan Nanoparticles Loaded with Legumain DNA Vaccine: Effect against Breast Cancer in Mice

Legumain-based DNA vaccines have potential to protect against breast cancer. However, the lack of a safe and efficient oral delivery system restricts its clinical application. Here, we constructed alginic acid-coated chitosan nanoparticles (A.C.NPs) as an oral delivery carrier for a legumain DNA vaccine. First, we tested its characteristic in acidic environments in vitro. DNA agarose electrophoresis data show that A.C.NPs protected DNA better from degradation in acidic solution (pH 1.5) than did chitosan nanoparticles (C.NPs). Furthermore, size distribution analysis showed that A.C.NPs tended to aggregate and form micrometer scale complexes in pH<2.7, while dispersing into nanoparticles with an increase in pH. Mice were intragastrically administrated A.C.NPs carrying EGFP plasmids and EGFP expression was detected in the intestinal Peyer’s patches. Full-length legumain plasmids were loaded into different delivery carriers, including C.NPs, attenuated Salmonella typhimurium and A.C.NPs. A.C.NPs loaded with empty plasmids served as a control. Oral vaccination was performed in the murine orthotopic 4T1 breast cancer model. Our data indicate that tumor volume was significantly smaller in groups using A.C.NPs or attenuated Salmonella typhimurium as carriers. Furthermore, splenocytes co-cultured them with 4T1 cells pre-stimulated with CoCl₂, which influenced the translocation of legumain from cytoplasm to plasma membrane, showed a 4.7 and 2.3 folds increase in active cytotoxic T lymphocytes (CD3⁺/CD8⁺/CD25⁺) when treated with A.C.NPs carriers compared with PBS C.NPs. Our study suggests that C.NPs coated with alginic acid may be a safe and efficient tool for oral delivery of a DNA vaccine. Moreover, a legumain DNA vaccine delivered orally with A.C.NPs can effectively improve autoimmune response and protect against breast cancer in mice.     

Targeting of Drugs to Solid Tumors Using Anti-Her2 Immunoliposomes

Abstract

Cancer therapy would clearly benefit from a carrier system capable of intracellular delivery of systemically administered drugs to cancer cells in solid tumors. Sterically stabilized immunoliposomes specific to the cells expressing HER2 protooncogene (anti-HER2 SIL), were designed by conjugating Fab’ fragments of a recombinant humanized anti-HER2 MAb to the distal termini of poly(ethylene glycol) chains on the surface of unilamellar liposomes (size 90–100 nm) of phosphatidylcholine, cholesterol, and poly (ethylene glycol)—derivatized phosphatidylethanolamine. Anti-HER2 SIL avidly and specifically bound to cultured HER2-overexpressing cancer cells (8,000–23,000 vesicles per cell) and became endocytosed (k_e = 0.022–0.033 min.^?1) via the coated pit pathway. Anti-HER2 SIL showed prolonged circulation lifetime in rats (blood MRT approx. 24 hours) and significantly increased antitumor activity of encapsulated doxorubicin against HER2-overexpressing human breast cancer xenografts in nude mice. Although the accumulation of anti-HER2 SIL in HER2-overexpressing tumor xenografts was not increased over that of non-targeted sterically stabilized liposomes (SL), microscopic examination revealed abundance of anti-HER2 SIL in the interstitial spaces, as well as within the cytoplasm of cancer cells, while identical liposomes lacking anti-HER2 Fab’ were located predominantly within tumor-resident macrophages. Anti-HER2 SIL, a targeted vehicle capable of in vivo intracellular delivery of substances to HER2-overexpressing solid cancers, enhances the potential for tumor targeting and opens new avenues for better treatment of cancer.     

Synthesis,Characterization and In Vitro Study of Biocompatible Cinnamaldehyde Functionalized Magnetite Nanoparticles (CPGF Nps) For Hyperthermia and Drug Delivery Applications in Breast Cancer

Cinnamaldehyde, the bioactive component of the spice cinnamon, and its derivatives have been shown to possess anti-cancer activity against various cancer cell lines. However, its hydrophobic nature invites attention for efficient drug delivery systems that would enhance the bioavailability of cinnamaldehyde without affecting its bioactivity. Here, we report the synthesis of stable aqueous suspension of cinnamaldehyde tagged Fe₃O₄ nanoparticles capped with glycine and pluronic polymer (CPGF NPs) for their potential application in drug delivery and hyperthermia in breast cancer. The monodispersed superparamagnetic NPs had an average particulate size of ∼20 nm. TGA data revealed the drug payload of ∼18%. Compared to the free cinnamaldehyde, CPGF NPs reduced the viability of breast cancer cell lines, MCF7 and MDAMB231, at lower doses of cinnamaldehyde suggesting its increased bioavailability and in turn its therapeutic efficacy in the cells. Interestingly, the NPs were non-toxic to the non-cancerous HEK293 and MCF10A cell lines compared to the free cinnamaldehyde. The novelty of CPGF nanoparticulate system was that it could induce cytotoxicity in both ER/PR positive/Her2 negative (MCF7) and ER/PR negative/Her2 negative (MDAMB231) breast cancer cells, the latter being insensitive to most of the chemotherapeutic drugs. The NPs decreased the growth of the breast cancer cells in a dose-dependent manner and altered their migration through reduction in MMP-2 expression. CPGF NPs also decreased the expression of VEGF, an important oncomarker of tumor angiogenesis. They induced apoptosis in breast cancer cells through loss of mitochondrial membrane potential and activation of caspase-3. Interestingly, upon exposure to the radiofrequency waves, the NPs heated up to 41.6°C within 1 min, suggesting their promise as a magnetic hyperthermia agent. All these findings indicate that CPGF NPs prove to be potential nano-chemotherapeutic agents in breast cancer.     

Design and Mechanism of On–Off Pulsed Drug Release Using Nonenteric Polymeric Systems via pH Modulation

The aim was to design a pH-sensitive pulsatile drug delivery system that allows for an on–off pulsed release of a drug using polyacrylic acid (PAA) blended with ethyl cellulose (EC) in different ratios. PAA, a polyelectrolyte polymer, exhibits a highly coiled conformation at low pH but a highly extended structure at high pH. Fumaric acid, which is an internal acidifying agent, was incorporated into the hydroxypropyl methylcellulose-based core tablets to create an acidic microenvironmental pH (pH_M). The concentration of fumaric acid inside the core tablet and the ratio of PAA/EC in the coating layer were very crucial in modulating drug release behaviors. When the fumaric acid was retained in the core tablet, it gave a more acidic pH_M, so that the PAA was kept in a highly coiled state in the coated film, which hindered drug release (“off” release pattern). Interestingly, the release profiles of the drug and fumaric acid from coated tablets showed the on–off pulsed pattern upon dissolution. Imaging analyses using scanning electron microscopy, near-infrared imaging, confocal laser scanning microscopy, and Fourier transform infrared spectroscopy confirmed this on–off release behavior of the drug and fumaric acid from coated tablets.     

Na+/H+ exchange in crayfish neurons: dependence on extracellular sodium and pH

Summary Intracellular pH (pH_i) regulation was studied in crayfish neurons with pH-, and Na⁺-sensitive microelectrodes. It was confirmed to involve both a HCO ₃ ^– -dependent and a HCO ₃ ^– -independent mechanism. The latter was identified as the amiloride-sensitive Na⁺/H⁺ exchange described in vertebrate cells. Its dependence on extracellular pH (pH_e) and Na⁺ concentration ([Na⁺]_e) was studied in CO₂-free external solutions at 20°C. The steady state pH_i and the rate constant (k) of the exponential pH_i recovery following an acid load were determined. At pH_e=7.5 and [Na⁺]_e=200 mM, the average steady state pH_i was 7.09±0.12 (as compared to 7.30±0.10 in the presence of 5 mM bicarbonate). The dependence of the rate constant of recovery on [Na⁺]_e could be described by Michaelis-Menten kinetics; at pH_e=7.5 the apparentK _m andK _max were 39 mM and 1.4 mmol·l^–1·min^–1, respectively. Decreasing pH_e reduced the rate of recovery, the variations ofk with pH_e conforming to a simple titration curve with an apparent pK of 7.05±0.21. These kinetic properties of the Na⁺/H⁺ exchange in crayfish neurons are similar to those described in vertebrate cells.Preliminary results were presented at the First International Congress of Comparative Physiology and Biochemistry (Liège, Belgium, 1984)     

Controllable release of self-assembled reduction-sensitive paclitaxel dimer prodrug and tetrandrine nanoparticles promotes synergistic therapy against multidrug-resistant cancer

BackgroundMultidrug resistance (MDR) is the main reason for chemotherapy failure. Nanocarriers combined delivery of anti-cancer drugs and MDR inhibitors is an effective strategy to avoid MDR and improve the anti-cancer activity of drugs.MethodsTwo paclitaxel (PTX) molecules are linked by disulfide bonds into PTX₂. Then, the PTX₂ and tetrandrine (TET) are coated together by mPEG-PLGA self-assembled NPs for combinational treatment. Microstructure, physiological stability, and cytotoxicity are characterized for the co-loaded NPs.ResultsThe NPs exhibit excellent suitability and blood safety for intravenous injection, specifically responsive to pH 6–7, and promptly initiate chemical degradation. Ex vivo fluorescence microscopy image studies indicate that co-loaded NPs increase drug penetration into cancer cells compared with free drugs. MTT assay demonstrates that co-loaded NPs have higher cytotoxicity against HeLa and the flow cytometric analysis shows that co-loaded NPs trigger more apoptosis than the free drugs. Reactive oxygen species (ROS) assay indicates that the drug-loaded NPs generated higher levels of ROS to accelerate apoptosis in HeLa cells.ConclusionsTET can get desirable effects of inhibiting the MDR in advance by binding with the active site on P-gp, then the disulfide bond of PTX₂ is broken by glutathione (GSH) in cancer cells and decomposed into PTX to inhibit cancer cell proliferation.General significanceOur studies indicate that the co-loaded NPs can potentially overcome the MDR of conventional chemotherapeutic agents.     

Phototoxic aptamers selectively enter and kill epithelial cancer cells

The majority of cancers arise from malignant epithelial cells. We report the design of synthetic oligonucleotides (aptamers) that are only internalized by epithelial cancer cells and can be precisely activated by light to kill such cells. Specifically, phototoxic DNA aptamers were selected to bind to unique short O-glycan-peptide signatures on the surface of breast, colon, lung, ovarian and pancreatic cancer cells. These surface antigens are not present on normal epithelial cells but are internalized and routed through endosomal and Golgi compartments by cancer cells, thus providing a focused mechanism for their intracellular delivery. When modified at their 5′ end with the photodynamic therapy agent chlorin e₆ and delivered to epithelial cancer cells, these aptamers exhibited a remarkable enhancement (>500-fold increase) in toxicity upon light activation, compared to the drug alone and were not cytotoxic towards cell types lacking such O-glycan-peptide markers. Our findings suggest that these synthetic oligonucleotide aptamers can serve as delivery vehicles in precisely routing cytotoxic cargoes to and into epithelial cancer cells.     

NHE1 mediates migration and invasion of HeLa cells via regulating the expression and localization of MT1‐MMP

Na⁺/H⁺ exchanger 1 (NHE1), acting as an important regulator of intracellular pH (pH_i) and extracellular pH (pH_e), has been known to play a key role in the metastasis of many solid tumours. However, the exact mechanism underlying these processes, especially in cervical cancer, is still poorly understood. In the current study, we first showed that the inhibition of NHE1 activity by the specific inhibitor cariporide could suppress migration and invasion of HeLa cells in vitro. Moreover, cariporide also reversed the enhanced migration and invasion in HeLa cells by overexpressed membrane‐type 1 matrix metalloproteinase (MT1‐MMP). Subsequently, our results showed that NHE1 regulated the expression of MT1‐MMP at both messenger RNA and protein levels as well as its localization. Meanwhile, we observed slight modification in the morphology of HeLa cell after treating with cariporide. The present work indicates that NHE1 mediates HeLa cell metastasis via regulating the expression and localization of MT1‐MMP and provides a theoretical basis for the development of novel therapeutic strategies targeting cervical cancer. Copyright © 2011 John Wiley & Sons, Ltd.     

Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines

In the current study, gefitinib loaded PLGA nanoparticles (GFT-PLGA-NPs) and chitosan coated PLGA nanoparticles (GFT-CS-PLGA-NPs) were synthesized to investigate the role of surface charge of NPs for developing drug delivery system for non-small-cell lung cancer (NSCLC). The developed NPs were evaluated for their size, PDI, zeta potential (ZP), drug entrapment, drug loading, DSC, FTIR, XRD, in vitro release profile, and morphology. The anti-cancer activity of GFT loaded PLGA NPs and GFT loaded CS-PLGA-NPs were examined in human A549 lung cancer cell lines. In vitro release studies of GFT-CS-PLGA-NPs showed more sustained release in comparison to GFT-PLGA-NPs due surface charge attraction of chitosan. In addition, viability of A549 cells decreases significantly with the increasing concentration of GFT-PLGA NPs and GFT-CS-PLGA-NPs when compared to that of pure GFT and blank PLGA NPs. In addition, the microscopic analysis and counting of viable cells also validate the cytotoxicity of the developed NPs. This investigation proved that the developed NPs would be efficient carriers to deliver GFT with improved efficacy against NSCLC.